Thyroid cancer differentiated · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Radioiodine and Selumetinib Variant #01 | — | R 462 396 | 28d | — | — | — | — | — |
Observation Partial | — | — | — | ~10.3 mo | ~37.1 mo | — | — | 65 |
Radioiodine ablation Variant #01 Partial | — | — | — | — | — | — | — | — |
3 of 3 regimens shown